Trials / Completed
CompletedNCT00073515
Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices
A Phase 2, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Alfimeprase for Restoring Function in Occluded Central Venous Catheters
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 115 (planned)
- Sponsor
- ARCA Biopharma, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial is for patients with a central venous catheter (a vascular access device) that is not functioning properly (unable to withdraw blood). The trial compares a new blood clot dissolving agent (alfimeprase) against the currently used treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alfimeprase |
Timeline
- First posted
- 2003-11-25
- Last updated
- 2010-02-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00073515. Inclusion in this directory is not an endorsement.